Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FAM153A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ISOC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00348 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DACH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SH2D4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASPDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC107 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIS18BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPME1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SVIL-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSPAN33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on